Pacific Heights Asset Management LLC Has $12.04 Million Stake in Agilent Technologies, Inc. $A

Pacific Heights Asset Management LLC boosted its stake in Agilent Technologies, Inc. (NYSE:A) by 56.9% during the 2nd quarter, Holdings Channel.com reports. The institutional investor owned 102,000 shares of the medical research company’s stock after buying an additional 37,000 shares during the period. Pacific Heights Asset Management LLC’s holdings in Agilent Technologies were worth $12,037,000 at the end of the most recent reporting period.

Several other institutional investors have also bought and sold shares of the stock. Terra Alpha Investments LLC boosted its stake in Agilent Technologies by 10.0% in the 2nd quarter. Terra Alpha Investments LLC now owns 26,644 shares of the medical research company’s stock valued at $3,144,000 after buying an additional 2,415 shares in the last quarter. St. James Investment Company LLC bought a new position in Agilent Technologies in the 2nd quarter valued at $208,000. VCI Wealth Management LLC raised its position in Agilent Technologies by 14.3% in the 2nd quarter. VCI Wealth Management LLC now owns 10,393 shares of the medical research company’s stock valued at $1,226,000 after purchasing an additional 1,298 shares during the last quarter. Journey Advisory Group LLC bought a new position in Agilent Technologies in the 2nd quarter valued at $2,434,000. Finally, Chicago Partners Investment Group LLC raised its position in Agilent Technologies by 85.9% in the 2nd quarter. Chicago Partners Investment Group LLC now owns 3,632 shares of the medical research company’s stock valued at $434,000 after purchasing an additional 1,678 shares during the last quarter.

Agilent Technologies Trading Up 2.0%

A stock opened at $145.79 on Wednesday. The company has a market cap of $41.33 billion, a P/E ratio of 34.22, a PEG ratio of 4.67 and a beta of 1.26. Agilent Technologies, Inc. has a twelve month low of $96.43 and a twelve month high of $153.84. The company has a quick ratio of 1.71, a current ratio of 2.25 and a debt-to-equity ratio of 0.53. The business has a fifty day moving average of $128.72 and a 200-day moving average of $118.37.

Agilent Technologies (NYSE:A) last released its earnings results on Wednesday, August 27th. The medical research company reported $1.37 earnings per share for the quarter, hitting analysts’ consensus estimates of $1.37. Agilent Technologies had a return on equity of 25.51% and a net margin of 17.97%.The company had revenue of $1.74 billion during the quarter, compared to the consensus estimate of $1.67 billion. During the same quarter in the previous year, the company posted $1.32 earnings per share. The firm’s quarterly revenue was up 10.1% on a year-over-year basis. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. As a group, equities research analysts expect that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Agilent Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 22nd. Investors of record on Tuesday, September 30th will be paid a dividend of $0.248 per share. The ex-dividend date of this dividend is Tuesday, September 30th. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.7%. Agilent Technologies’s payout ratio is 23.24%.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on A. Barclays lifted their price objective on Agilent Technologies from $125.00 to $150.00 and gave the company an “equal weight” rating in a research report on Thursday, October 2nd. Rothschild Redb upgraded Agilent Technologies to a “strong-buy” rating in a research report on Wednesday, October 8th. Wall Street Zen upgraded Agilent Technologies from a “hold” rating to a “buy” rating in a research report on Friday, October 3rd. JPMorgan Chase & Co. boosted their target price on Agilent Technologies from $155.00 to $165.00 and gave the stock an “overweight” rating in a research report on Thursday, October 9th. Finally, Evercore ISI boosted their target price on Agilent Technologies from $128.00 to $140.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 7th. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and six have given a Hold rating to the company. Based on data from MarketBeat, Agilent Technologies has a consensus rating of “Moderate Buy” and a consensus target price of $149.62.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.